M.J. Kaashoek

1.6k total citations
27 papers, 1.3k citations indexed

About

M.J. Kaashoek is a scholar working on Epidemiology, Immunology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, M.J. Kaashoek has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 17 papers in Immunology and 12 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in M.J. Kaashoek's work include Herpesvirus Infections and Treatments (24 papers), T-cell and Retrovirus Studies (17 papers) and Vector-Borne Animal Diseases (12 papers). M.J. Kaashoek is often cited by papers focused on Herpesvirus Infections and Treatments (24 papers), T-cell and Retrovirus Studies (17 papers) and Vector-Borne Animal Diseases (12 papers). M.J. Kaashoek collaborates with scholars based in Netherlands, Serbia and Belgium. M.J. Kaashoek's co-authors include J.T. van Oirschot, F.A.M. Rijsewijk, Jasper J. Quak, A. L. J. Gielkens, A. Moerman, Mieke A. Maris-Veldhuis, K. Weerdmeester, F. A. C. van Engelenburg, H. L. B. M. Klaasen and Josip Madić and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of General Virology and Vaccine.

In The Last Decade

M.J. Kaashoek

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J. Kaashoek Netherlands 18 950 580 448 404 168 27 1.3k
Julien Thiry Belgium 13 760 0.8× 432 0.7× 281 0.6× 221 0.5× 86 0.5× 33 961
I. Pow United Kingdom 19 829 0.9× 401 0.7× 528 1.2× 190 0.5× 158 0.9× 45 1.2k
Naomi S. Taus United States 23 1.1k 1.1× 500 0.9× 618 1.4× 194 0.5× 157 0.9× 64 1.4k
D.M. Jessett Kenya 20 758 0.8× 511 0.9× 366 0.8× 244 0.6× 105 0.6× 47 1.2k
Cristina W. Cunha United States 18 631 0.7× 337 0.6× 376 0.8× 152 0.4× 71 0.4× 54 867
J. Brinkhof Netherlands 19 468 0.5× 383 0.7× 240 0.5× 166 0.4× 153 0.9× 36 1.0k
A. A. Schudel Argentina 19 377 0.4× 537 0.9× 359 0.8× 181 0.4× 50 0.3× 50 1.0k
Jarasvech Chinsangaram United States 21 508 0.5× 955 1.6× 584 1.3× 184 0.5× 169 1.0× 30 2.0k
J. T. Bryans United States 15 724 0.8× 329 0.6× 226 0.5× 252 0.6× 134 0.8× 33 1.2k
Michel Bublot Belgium 27 1.5k 1.6× 524 0.9× 182 0.4× 311 0.8× 203 1.2× 55 1.7k

Countries citing papers authored by M.J. Kaashoek

Since Specialization
Citations

This map shows the geographic impact of M.J. Kaashoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Kaashoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Kaashoek more than expected).

Fields of papers citing papers by M.J. Kaashoek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Kaashoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Kaashoek. The network helps show where M.J. Kaashoek may publish in the future.

Co-authorship network of co-authors of M.J. Kaashoek

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Kaashoek. A scholar is included among the top collaborators of M.J. Kaashoek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Kaashoek. M.J. Kaashoek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Halder, Marlies, Marion F. Gruber, Klaus Cußler, et al.. (2019). Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement. Biologicals. 63. 101–105. 12 indexed citations
3.
Rijsewijk, F.A.M., M.J. Kaashoek, Jan Langeveld, et al.. (2000). Epitopes on glycoprotein E and on the glycoprotein E/glycoprotein I complex of bovine herpesvirus 1 are expressed by all of 222 isolates and 11 vaccine strains. Archives of Virology. 145(5). 921–936. 11 indexed citations
4.
Oirschot, J.T. van, M.J. Kaashoek, Mieke A. Maris-Veldhuis, & F.A.M. Rijsewijk. (1999). Strains of bovine herpesvirus 1 that do not express an epitope on glycoprotein E in cell culture still induce antibodies that can be detected in a gE-blocking ELISA. Veterinary Microbiology. 65(2). 103–113. 9 indexed citations
5.
Jong, M.C.M. de, P. Franken, K. Frankena, et al.. (1998). An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. Vaccine. 16(2-3). 265–271. 55 indexed citations
6.
Kaashoek, M.J., F.A.M. Rijsewijk, Robin Ruuls, et al.. (1998). Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene. Vaccine. 16(8). 802–809. 78 indexed citations
7.
Oirschot, J.T. van, M.J. Kaashoek, Mieke A. Maris-Veldhuis, K. Weerdmeester, & F.A.M. Rijsewijk. (1997). An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. Journal of Virological Methods. 67(1). 23–34. 74 indexed citations
8.
Kaashoek, M.J., et al.. (1997). Identification of epitopes on glycoprotein C of bovine herpesvirus 1 that allow differentiation between "IBR-like" and "IPV-like" strains. Socio-Environmental Systems Modeling. 1 indexed citations
9.
10.
Kaashoek, M.J., et al.. (1996). An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Veterinary Microbiology. 52(3-4). 223–234. 55 indexed citations
11.
Kaashoek, M.J., F. A. C. van Engelenburg, A. Moerman, et al.. (1996). Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants. Veterinary Microbiology. 48(1-2). 143–153. 44 indexed citations
12.
Kaashoek, M.J. & J.T. van Oirschot. (1996). Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine. Veterinary Microbiology. 53(1-2). 191–197. 30 indexed citations
13.
Kaashoek, M.J., F.A.M. Rijsewijk, & J.T. van Oirschot. (1996). Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection. Veterinary Microbiology. 53(1-2). 103–110. 48 indexed citations
14.
Bosch, Johan G., K. Frankena, P. Franken, et al.. (1996). Bovine herpesvirus 1 marker vaccines reduce the incidence of infections.. Socio-Environmental Systems Modeling. 42–44. 2 indexed citations
15.
Denis, Martine, Emmanuel Hanon, Frans A.M. Rijsewijk, et al.. (1996). The role of glycoproteins gC, gE, gI and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1. Veterinary Microbiology. 53(1-2). 121–132. 11 indexed citations
16.
Kaashoek, M.J., P. J. Straver, E.M.A. van Rooij, Jasper J. Quak, & J.T. van Oirschot. (1996). Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects. Veterinary Record. 139(17). 416–421. 57 indexed citations
17.
Oirschot, J.T. van, M.J. Kaashoek, & F.A.M. Rijsewijk. (1996). Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Veterinary Microbiology. 53(1-2). 43–54. 67 indexed citations
18.
19.
Denis, Martine, M.J. Kaashoek, J.T. van Oirschot, P.P. Pastoret, & Étienne Thiry. (1994). Quantitative assessment of the specific CD4+ T lymphocyte proliferative response in bovine herpesvirus 1 immune cattle. Veterinary Immunology and Immunopathology. 42(3-4). 275–286. 12 indexed citations
20.
Engelenburg, F. A. C. van, M.J. Kaashoek, F.A.M. Rijsewijk, et al.. (1994). A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. Journal of General Virology. 75(9). 2311–2318. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julien Thiry Breakdown of academic impact, for papers by I. Pow Breakdown of academic impact, for papers by Naomi S. Taus Breakdown of academic impact, for papers by D.M. Jessett Breakdown of academic impact, for papers by Cristina W. Cunha Breakdown of academic impact, for papers by J. Brinkhof Breakdown of academic impact, for papers by A. A. Schudel Breakdown of academic impact, for papers by Jarasvech Chinsangaram Breakdown of academic impact, for papers by J. T. Bryans Breakdown of academic impact, for papers by Michel Bublot
Rankless by CCL
2026